Keyphrases
Active Response
20%
Adjuvant Therapy
20%
Antifungal Combination
20%
Antifungal Therapy
20%
Antifungal Tolerance
20%
Antimicrobial
20%
Aspergillus Fumigatus
100%
Azoles
100%
Bacterial Infection
40%
Chronic Aspergillosis
20%
Drug Absorption
20%
Drug Combination
20%
Drug Concentration
20%
Extended Period
60%
Filamentous Fungi
20%
First-line Therapy
20%
Fumigatus
40%
Fungal Infection
20%
Fungal Pathogens
20%
Galleria Mellonella Model
20%
Human Aspergillosis
20%
Immunosuppression
20%
Infection Model
40%
Invasive Aspergillosis
20%
Low Dose Rate
20%
Lung
20%
Mechanism of Action
40%
Mutually Exclusive
20%
Pathogenic Microorganisms
20%
Patient Management
20%
Persisters
20%
Resistance Emergence
20%
Resistant Isolate
20%
Spread of Resistance
20%
Therapeutic Potential
20%
Transcriptional Profile
20%
Treatment Efficacy
20%
Treatment Failure
80%
Underlying Lung Disease
20%
Voriconazole
100%
Immunology and Microbiology
Aspergillus fumigatus
100%
Drug Absorption
33%
Drug Concentration
33%
Filamentous Fungus
33%
Galleria mellonella
33%
Immunosuppression
33%
Infectious Agent
66%
Minimum Inhibitory Concentration
33%
Pathogenic Microbes
33%